| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |